AAAAAA

   
Results: 1-18 |
Results: 18
ANALYSIS OF THE ROLE OF TYPE-1 CORE O-GLYCANS IN THE BINDING OF ANTI-MUC1 ANTIBODIES BY CYTOFLUOROMETRY AND SYNTHETIC PEPTIDE GLYCOPEPTIDE BINDING-INHIBITION STUDIES/
Authors: REDDISH MA SURESH MR KOGANTY RR FORTIER S BARONIC L BERG A MICHAEL B LONGENECKER BM
Citation: Ma. Reddish et al., ANALYSIS OF THE ROLE OF TYPE-1 CORE O-GLYCANS IN THE BINDING OF ANTI-MUC1 ANTIBODIES BY CYTOFLUOROMETRY AND SYNTHETIC PEPTIDE GLYCOPEPTIDE BINDING-INHIBITION STUDIES/, Tumor biology, 19, 1998, pp. 57-66
THE ISCHEMIC OPTIC NEUROPATHY DECOMPRESSION TRIAL (IONDT) - DESIGN AND METHODS
Authors: KENNERDELL J TYUTYUNIKOV A EDWARDS R GOODGLICK T LANG D PEELE K CHUNG S KNAUP P MEKELBURG D HOLDS J SELHORST J MALTON M ARMSTRONG S MCCRACKEN Y BENJAMIN E BROOKS E DELLINGER C MEDLIN TH KINSLER B MCOWEN M RUSSELL D SAUNDERS T KOSMORSKY G KISS T REINHARD C EDGERTON J FECKO T HANSON S KRAUS B ROSS D TOMSAK N VARGO P WALSH L WILLIS R FELDON S LEVIN L ZIMMERMAN K ANDERSON K CORTEZ R DEBLANC K HULSE J MORALES R NICHOLS T REYES L RODARTEOCHOA N ROMO D SADUN A STEBER M WALONKER F NEWMAN NJ LOUPE D COFFMAN D COLE H WOJNO T SKARF B WOJTALA C CROSWELL M GILROY W MAGELI C MCDONALD D PONKA G TANG R HAMLIN M CURTIS J HYDE K MACK K TELLO P ARNOLD A MULLEN M CIBENER B VEGA M BALLENBERG B BOLTON A GARCIA J GOLDBERG R GORDON L HENEGHAN M KRAUS H SANGUINET J STALLING R YADEGARAN J CORNBLATH W MICHAEL B CAMPBELL D CAUDILL C NELSON C TROBE J JOHNSON LN BAKER G COBB C CUSTER P TURNER S WILSON R YOUNGE B LEAVITT J NIELSEN R ALLEN J EICKHOFF B GARRITY J LADSTEN J LEBARRON K LINK T ROSTVOLD J WEBER K FELTON W OLIVER T SMITH S GABRIEL D DAVID D FENDELANDER L GELLER D JORDAN T KIM C MUNGER C ROMANDY JA SANBORN G SCHWARTZ B SHEUSI C SMITH C TALLEY K THIMMAPPA S KAUFMAN D EGGENBERGER E BICKERT S GRANADIER R HOLLIDAY S MOORE T VARADARAJAN J FRIEDMAN D JONES P AMIN H BERSANI T BRIGLIN C FOOKS J GRAHAM M JAMES M MICHALEC G NGUYEN H HORTON J CHANG M ABER LA LINDSTROM E SEIFF S GUY J ZAM ZS FRANCIS A HAMED L LESSNER A MCDAVID D SHAMIS D GOODWIN J LINDEMAN ME SULLIVAN E BOBAK P PUTTERMAN A BAKER R BECK J COWEN D EPSTEIN A HANSON M SCOGGINS T KELMAN S FRANK C BLAKE A RODAVITCH AM GORE B HEROUX M KALSI R KRAUCH C MILLAR MA CHALAM K WOLIN M MUNN B BRADY RJ HANSEN R BRIGGS M DANNER B SIMONS B STEWART A DIGRE K ERICKSON J MALMQUISTWEBB L BLACKBURN T BAGGALEY S ANDERSON R JUAREZ C KAYE B LANGER P MISHRA A MORRIS P OSBORN S PATEL B STAKER S WARNER J NEWMAN S EVANS C AYLOR A CHILDRESS C DICKERSON H FLEMING J HARRIS N HOYLE LS MURPHY E SCOTT J SMALL T SUMMERVILLE K TERRELL M TYLER L LINDBERG J ELLIS B BREEN L MICHAEL M CAMPBELL C GROVES N HOBSON R MCGREGOR G SHEPHERD L COHN E CUMMING K MANATREY P CASEY S JOHNSON J KRONNER C REGAN V STREASICK P ELMAN M METZEL D DICKERSIN K HOOPER F SCHERER R CRAWLEY B HINER C HOWARD L LAGENBERG P LURYE O MASIERO J MCCARTER R RIEDEL S SOTOS M SPIOCH L STARR J URBAN J WARING M WILSON PD EVERETT D FISHER M AITKEN P BECK R LACROIX A LESSELL S MACLEAN K KOSMORSKY D SEIFF SR
Citation: J. Kennerdell et al., THE ISCHEMIC OPTIC NEUROPATHY DECOMPRESSION TRIAL (IONDT) - DESIGN AND METHODS, Controlled clinical trials, 19(3), 1998, pp. 276-296
OUTCOME AND PERFORMANCE OF THE TESIO TWIN CATHETER SYSTEM PLACED FOR HEMODIALYSIS ACCESS
Authors: WIVELL WA DAVID LR BRIAN B MICHAEL B
Citation: Wa. Wivell et al., OUTCOME AND PERFORMANCE OF THE TESIO TWIN CATHETER SYSTEM PLACED FOR HEMODIALYSIS ACCESS, Radiology, 209P, 1998, pp. 1413-1413
EXPRESSION OF LEPTIN RECEPTOR IN HUMAN KIDNEY AND CORRELATION OF LEPTIN LEVELS WITH NUTRITIONAL PARAMETERS IN HEMODIALYSIS-PATIENTS
Authors: MICHAEL B YONG G DUNN S MCCUE P LYNN R CONSIDINE R SHARMA K
Citation: B. Michael et al., EXPRESSION OF LEPTIN RECEPTOR IN HUMAN KIDNEY AND CORRELATION OF LEPTIN LEVELS WITH NUTRITIONAL PARAMETERS IN HEMODIALYSIS-PATIENTS, Journal of the American Society of Nephrology, 8, 1997, pp. 2907-2907
INFORMED CONSENT AND CANCER CLINICAL-TRIALS
Authors: MICHAEL B
Citation: B. Michael, INFORMED CONSENT AND CANCER CLINICAL-TRIALS, European journal of cancer, 33, 1997, pp. 1010-1010
FAST ISOLATION OF RNA TO DETECT EXPRESSION OF TUMOR-MARKERS
Authors: SCHENK JA HILLEBRAND T LUBBE L HEYMANN S BOTTGER M MICHAEL B BENDZKO P
Citation: Ja. Schenk et al., FAST ISOLATION OF RNA TO DETECT EXPRESSION OF TUMOR-MARKERS, Journal of clinical laboratory analysis, 11(6), 1997, pp. 340-342
EFFECTS OF ISRADIPINE ON RENAL HEMODYNAMICS IN RENAL-TRANSPLANT PATIENTS TREATED WITH CYCLOSPORINE
Authors: AHMED K MICHAEL B BURKE JF
Citation: K. Ahmed et al., EFFECTS OF ISRADIPINE ON RENAL HEMODYNAMICS IN RENAL-TRANSPLANT PATIENTS TREATED WITH CYCLOSPORINE, Clinical nephrology, 48(5), 1997, pp. 307-310
A 6-MONTH STUDY OF LOW-DOSE RECOMBINANT-HUMAN-ERYTHROPOIETIN ALONE AND IN COMBINATION WITH ANDROGENS FOR THE TREATMENT OF ANEMIA IN CHRONIC-HEMODIALYSIS PATIENTS
Authors: GAUGHAN WJ LISS KA DUNN SR MANGOLD AM BUHSMER JP MICHAEL B BURKE JF
Citation: Wj. Gaughan et al., A 6-MONTH STUDY OF LOW-DOSE RECOMBINANT-HUMAN-ERYTHROPOIETIN ALONE AND IN COMBINATION WITH ANDROGENS FOR THE TREATMENT OF ANEMIA IN CHRONIC-HEMODIALYSIS PATIENTS, American journal of kidney diseases, 30(4), 1997, pp. 495-500
PLASMA LEPTIN IS PARTLY CLEARED BY THE KIDNEY AND IS ELEVATED IN HEMODIALYSIS-PATIENTS
Authors: SHARMA K CONSIDINE RV MICHAEL B DUNN SR WEISBERG LS KURNIK BRC KURNIK PB OCONNOR J SINHA M CARO JF
Citation: K. Sharma et al., PLASMA LEPTIN IS PARTLY CLEARED BY THE KIDNEY AND IS ELEVATED IN HEMODIALYSIS-PATIENTS, Kidney international, 51(6), 1997, pp. 1980-1985
FEMALE HEADS OF PATRIARCHAL HOUSEHOLDS - THE BAGGARA
Authors: MICHAEL B
Citation: B. Michael, FEMALE HEADS OF PATRIARCHAL HOUSEHOLDS - THE BAGGARA, Journal of comparative family studies, 28(2), 1997, pp. 170
AUDIT OF WASTE COLLECTED OVER ONE WEEK FROM 10 DENTAL PRACTICES - A PILOT-STUDY
Authors: FARMER GM STANKIEWICZ N MICHAEL B WOJCIK A LIM Y IVKOVIC D RAJAKULENDRAN J
Citation: Gm. Farmer et al., AUDIT OF WASTE COLLECTED OVER ONE WEEK FROM 10 DENTAL PRACTICES - A PILOT-STUDY, Australian dental journal, 42(2), 1997, pp. 114-117
THE 5-YEAR RISK OF MS AFTER OPTIC NEURITIS - EXPERIENCE OF THE OPTIC NEURITIS TREATMENT TRIAL
Authors: BRODSKY M JAY W JOHNSON P LAMEY D CAIN S WHEELER B LAM B NAZARIAN S NICHOLS J BUCKHOLTS A FORD R ORENGONANIA S MCCRARY J ROLAK L SLIGHT B CHUNG S GROSS R HOWARD A LAI E FRADY P KATZ B FOLTOS C AMBROSIO T CRUZ T HAWKER N SWAHN T BARSNESS D CHRISTKUHN J GAFFNEY M LOEY N BUCKLEY E ANDERSON M VALENTINE G MASSEY E POLLOCK S RADTKE R DUNCAN L PATTERSON D GUY J ZAM S BURKE R FRANCIS A SHAMIS D CHROUSOS G BURT E KATTAH J GOODWIN J ASLAN R LINDEMAN M SULLIVAN L BOBAK P THOMPSON S CORBETT J MUSSER C DONAHUE S FARRELL T JOHNSTONMCNUSSEN P KARDON R MISHRA A NEAHRING R WALL M FOUNTAIN C SAVINO P WARD S DEVLIN N BOSLEY T CANTOR C MCCLOSKEY L SERGOTT R DAVIS A EDWARDS R MORTON D MILLER N MEDURA M PUTZULO C BUCHHOLZ D REICH S REPKA T WEST L TROBE J CASTILLO R CAUDILL C CORNBLATH W MICHAEL B KAUFMAN D HOLLIDAY S BICKERT S FROEHLICH J KOKINAKIS J EGGENBERGER E MYINT S BARRIS M ROSICK E KUPERSMITH M LANGER R ADDESSI A WEINMAN J FROMER E WAHBA S SHULTS W BOLY L BEARDSLEY C DREYER R HERNDON R WILSON R ARENDS J BEAUDRY T SMITH C KUDER D MACKINNON G SMITH S SPARENBURG J TRAN E BECK R MOKE P ZAJAC L BLAIR RC LESTER L GILLESPIE H MISKALA P JUREIDINI F KAHN D MHAMDI M KELTNER J JOHNSON C SPURR J SHAPIRO L HAKIM H CLAUNCH D BEAM D OWENSBY D ANDERSON MA CLEARY P PATY D MOWERY R EVERETT D
Citation: M. Brodsky et al., THE 5-YEAR RISK OF MS AFTER OPTIC NEURITIS - EXPERIENCE OF THE OPTIC NEURITIS TREATMENT TRIAL, Neurology, 49(5), 1997, pp. 1404-1413
A 6 MONTH STUDY OF LOW-DOSE RECOMBINANT-HUMAN-ERYTHROPOIETIN ALONE AND IN COMBINATION WITH ANDROGEN FOR THE TREATMENT OF ANEMIA IN CHRONIC-HEMODIALYSIS PATIENTS
Authors: LISS KA GAUGHAN WJ DUNN SR MICHAEL B GOLDMAN JM ARMENTI VT MANGOLD A BUHSMER JP BURKE JF
Citation: Ka. Liss et al., A 6 MONTH STUDY OF LOW-DOSE RECOMBINANT-HUMAN-ERYTHROPOIETIN ALONE AND IN COMBINATION WITH ANDROGEN FOR THE TREATMENT OF ANEMIA IN CHRONIC-HEMODIALYSIS PATIENTS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1206-1206
PLASMA LEPTIN IS CLEARED BY THE KIDNEY AND IS MARKEDLY ELEVATED IN HEMODIALYSIS-PATIENTS
Authors: SHARMA K MICHAEL B DUNN S WEISBERG L KURNIK B KURNIK P OCONNOR J CONSIDINE R SINHA M CARO JF
Citation: K. Sharma et al., PLASMA LEPTIN IS CLEARED BY THE KIDNEY AND IS MARKEDLY ELEVATED IN HEMODIALYSIS-PATIENTS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 3085-3085
SPONTANEOUS CLOSTRIDIUM-SEPTICUM MYONECROSIS
Authors: MICHAEL B
Citation: B. Michael, SPONTANEOUS CLOSTRIDIUM-SEPTICUM MYONECROSIS, Complications in surgery, 13(4), 1994, pp. 550-555
THE ADVANCED GLAUCOMA INTERVENTION STUDY (AGIS) .1. STUDY DESIGN AND METHODS AND BASE-LINE CHARACTERISTICS OF STUDY PATIENTS
Authors: BROWN RH LYNCH M LEEF D GUNSBY J LOBER K MOORE K STEPKA C VELATHOMAS A GAASTERLAND DE COYLE E HUNDLEY M ASHBURN F VAYER L MICHELITSCH K LAUBER S BURT E RAE A WEBER PA DERICK R MCKINNEY K MOORE D BAKER ND KAPETANSKY F LEHMAN D GLOECKNER B SHARF LJ ROMANS B SATTERWHITE Y SIMMONS L HARBIN TS OZMENT RR WRIGHT J BUTLER L LASALLE J PERRY M NUMMERDOR D WILLE L ECKEL A SESSION C MARTIN A CYRLIN MN FAZIO R WILENSKY JT LINDENMUTH K NAIL CA RATHBONE D GATES V TADELMAN M SONTY S HOPKINS G HIGGINBOTHAM EJ SCHOLES G UVA R PAPPAS L FROHLICHSTEIN D FIENE J BERGSTROM TJ LICHTER PR STANDARDI C ZIEHMSCOTT J PAPIERNIAKDUBIEL R POLLACKRUNDLE C SKUTA GL BEESON C CREW RP KRUSEKE L MICHAEL B DEDERIAN J WICKER D AARON D BIRK J VANHECK T ALLEN RC NEWMAN SA NORLUND JR FENDLEY CK BERGHUIS C CHISHOLM J EVANS C MURPHY E SCHOTT LJ FORNILI R SCHWARTZ AL WEISS H WEHRLY S PAPPAS S ODEA M BOECKL A LOPEZ P CARMODY K MERCER R MONKS V VAWTER K WITOL CV CIRONE M GURLEY J REED C BROWNING J HARRIS E KATZ LJ SPAETH GL WILSON RP SAMUEL F BLOCK A KAO S BEKERSHOFF CC CAPRIOLI J MILLER E ROCHE M GROTTOLE G LEONE A TRESSLER C EDERER F SULLIVAN EK WAGNER EL ENTLER G BRADFORD M TOMLIN KL STINE E LINDBLAD AS KNOKE JD DENEKAS M SMITH C VOSS T MOWERY RL LYNCH G GOFF F FURBERG CD CONNETT JE DAVIS MD DUEKER DK GREEN SB HAMILTON MP SCHNEIDERMAN MA KASSOFF A MORRIS M PALMBERG PF
Citation: Rh. Brown et al., THE ADVANCED GLAUCOMA INTERVENTION STUDY (AGIS) .1. STUDY DESIGN AND METHODS AND BASE-LINE CHARACTERISTICS OF STUDY PATIENTS, Controlled clinical trials, 15(4), 1994, pp. 299-325
METHOTREXATE IS EFFECTIVE IN PREVENTING ACUTE AND POTENTIALLY CHRONICRENAL-ALLOGRAFT REJECTION
Authors: MICHAEL B FRANCOS GC BURKE JF GAUGHAN WI
Citation: B. Michael et al., METHOTREXATE IS EFFECTIVE IN PREVENTING ACUTE AND POTENTIALLY CHRONICRENAL-ALLOGRAFT REJECTION, Transplantation proceedings, 26(5), 1994, pp. 3046-3047
CHRONIC RENAL-DISEASE - NEW THERAPIES TO DELAY KIDNEY REPLACEMENT
Authors: MICHAEL B BURKE JF
Citation: B. Michael et Jf. Burke, CHRONIC RENAL-DISEASE - NEW THERAPIES TO DELAY KIDNEY REPLACEMENT, Geriatrics, 49(8), 1994, pp. 33-38
Risultati: 1-18 |